Literature DB >> 2790635

Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost.

B G Hutchison.   

Abstract

Response rate, validity and cost of measurement of influenza vaccination status by mailed questionnaire were studied among seniors enrolled in a group family practice. The response rate to the questionnaire was 73%, 85% and 90% after one, two and three mailings, respectively. Questionnaire responses regarding influenza vaccination were compared with vaccination status as determined by review of office records. For the immediately preceding vaccination period, agreement beyond chance (Kappa statistic) between questionnaire responses and office records was .88. When questionnaire responses were assessed against a "gold standard" of office records supplemented by telephone interview of apparent false positives, the questionnaire performed with a sensitivity of .93 (95% CI .87-.96) and specificity of .98 (95% CI .96-.99). As assessed by records review, questionnaire respondents were four times more likely to have received influenza vaccine than non-respondents (p less than .003, 2-tailed).

Mesh:

Substances:

Year:  1989        PMID: 2790635

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  12 in total

1.  Racial and ethnic disparities in influenza vaccination among elderly adults.

Authors:  María C Rangel; Victor J Shoenbach; Kristen A Weigle; Vijaya K Hogan; Ronald P Strauss; Shrikant I Bangdiwala
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

2.  Impact of the 2004 influenza vaccine shortage on patients from inner city health centers.

Authors:  Richard K Zimmerman; Melissa Tabbarah; Mary Patricia Nowalk; Mahlon Raymund; Stephen A Wilson; Ann McGaffey; J Todd Wahrenberger; Bruce Block; Edmund M Ricci
Journal:  J Urban Health       Date:  2007-05       Impact factor: 3.671

3.  Trends in influenza vaccine coverage and vaccine hesitancy in Canada, 2006/07 to 2013/14: results from cross-sectional survey data.

Authors:  Sarah A Buchan; Jeffrey C Kwong
Journal:  CMAJ Open       Date:  2016-08-19

4.  Using physician billing claims from the Ontario Health Insurance Plan to determine individual influenza vaccination status: an updated validation study.

Authors:  Kevin L Schwartz; Nathaniel Jembere; Michael A Campitelli; Sarah A Buchan; Hannah Chung; Jeffrey C Kwong
Journal:  CMAJ Open       Date:  2016-08-22

5.  Impact of pharmacist administration of influenza vaccines on uptake in Canada.

Authors:  Sarah A Buchan; Laura C Rosella; Michael Finkelstein; David Juurlink; Jennifer Isenor; Fawziah Marra; Anik Patel; Margaret L Russell; Susan Quach; Nancy Waite; Jeffrey C Kwong
Journal:  CMAJ       Date:  2016-08-08       Impact factor: 8.262

6.  Educational content and the effectiveness of influenza vaccination reminders.

Authors:  K Armstrong; M Berlin; J S Schwartz; K Propert; P A Ubel
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

7.  Validation of influenza and pneumococcal vaccine status in adults based on self-report.

Authors:  P Mangtani; A Shah; J A Roberts
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

8.  Adherence and factors associated with influenza vaccination among subjects with asthma in Spain.

Authors:  J M Santos-Sancho; A López-de Andrés; I Jimenez-Trujillo; V Hernández-Barrera; P Carrasco-Garrido; P Astasio-Arbiza; R Jimenez-Garcia
Journal:  Infection       Date:  2013-02-12       Impact factor: 3.553

9.  The impact of the 2004-2005 influenza vaccine shortage in the Veterans Health Administration.

Authors:  Leila C Kahwati; John R Elter; Kristy A Straits-Tröster; Linda S Kinsinger; Victoria J Davey
Journal:  J Gen Intern Med       Date:  2007-06-02       Impact factor: 5.128

10.  Factors associated with influenza vaccine uptake in older adults living in the community in Singapore.

Authors:  L W Ang; J Cutter; L James; K T Goh
Journal:  Epidemiol Infect       Date:  2016-12-08       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.